Comparison of 2 synthetically generated recombinant prions

Prion

Volumn 8, Issue 2, 2014, Pages 215-220

  Zhang, Yi ^a,b   Wang, Fei ^b,c   Wang, Xinhe ^b,c   Zhang, Zhihong ^a   Xu, Yuanyuan ^a   Yu, Guohua ^a   Yuan, Chonggang ^a   Ma, Jiyan ^a,b,c  

^a B326 Science Building   (China)

^b OHIO STATE UNIVERSITY   (United States)

^c VAN ANDEL RESEARCH INSTITUTE   (United States)

Author keywords

Bioassay; GuHCl denaturation assay; Histopathology; Prion; Recombinant prion; Recombinant PrP; SPMCA

Indexed keywords

PRION PROTEIN; RECOMBINANT PRION; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOCHEMISTRY; COMPARATIVE STUDY; CONTROLLED STUDY; IN VITRO STUDY; INOCULATION; MOUSE; NONHUMAN; PRION DISEASE; WHITE MATTER; ANIMAL; BRAIN; GENETICS; METABOLISM; PATHOLOGY;

ANIMALS; BRAIN; MICE; RECOMBINANT PROTEINS;

EID: 84907560431     PISSN: 19336896     EISSN: 1933690X     Source Type: Journal    
DOI: 10.4161/pri.28669     Document Type: Article

References (37)

1. Prusiner SB. Prions. Proc Natl Acad Sci USA 1998; 95:13363-83; PMID:9811807; http://dx.doi.org/10.1073/pnas.95.23.13363
2. Aguzzi A, Sigurdson C, Heikenwaelder M. Molecular mechanisms of prion pathogenesis. Annu Rev Pathol 2008; 3:11-40; PMID:18233951; http://dx.doi.org/10.1146/annurev.pathmechdis.3.121806.154326
3. Prusiner SB. Novel proteinaceous infectious particles cause scrapie. Science 1982; 216:136-44; PMID:6801762; http://dx.doi.org/10.1126/science.6801762
4. Caughey B, Chesebro B. Prion protein and the transmissible spongiform encephalopathies. Trends Cell Biol 1997; 7:56-62; PMID:17708907; http://dx.doi.org/10.1016/S0962-8924(96)10054-4
5. Parchi P, Zou W, Wang W, Brown P, Capellari S, Ghetti B, Kopp N, Schulz-Schaeffer WJ, Kretzschmar HA, Head M W, et al. Genetic influence on the structural variations of the abnormal prion protein. Proc Natl Acad Sci USA 2000; 97:10168-72; PMID:10963679; http://dx.doi.org/10.1073/pnas.97.18.10168
6. Saborio GP, Permanne B, Soto C. Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding. Nature 2001; 411: 810-3; PMID:11459061; http://dx.doi.org/10.1038/35081095
7. Castilla J, Saá P, Morales R, Abid K, Maundrell K, Soto C. Protein misfolding cyclic amplification for diagnosis and prion propagation studies. Methods Enzymol 2006; 412:3-21; PMID:17046648; http://dx.doi.org/10.1016/S0076-6879(06)12001-7
8. Castilla J, Saá P, Hetz C, Soto C. In vitro generation of infectious scrapie prions. Cell 2005; 121:195-206; PMID:15851027; http://dx.doi.org/10.1016/j.cell.2005.02.011
9. Wang F, Wang X, Yuan CG, Ma J. Generating a prion with bacterially expressed recombinant prion protein. Science 2010; 327:1132-5; PMID:20110469; http://dx.doi.org/10.1126/science.1183748
10. Wang F, Zhang Z, Wang X, Li J, Zha L, Yuan CG, Weissmann C, Ma J. Genetic informational RNA is not required for recombinant prion infectivity. J Virol 2012; 86:1874-6; PMID:22090130; http://dx.doi.org/10.1128/JVI.06216-11
11. Zhang Z, Zhang Y, Wang F, Wang X, Xu Y, Yang H, Yu G, Yuan C, Ma J. De novo generation of infectious prions with bacterially expressed recom-binant prion protein. FASEB J 2013; 27:4768-75; PMID:23970796; http://dx.doi.org/10.1096/fj.13-233965
12. Kim JI, Cali I, Surewicz K, Kong Q, Raymond GJ, Atarashi R, Race B, Qing L, Gambetti P, Caughey B, et al. Mammalian prions generated from bacterially expressed prion protein in the absence of any mammalian cofactors. J Biol Chem 2010; 285:14083-7; PMID:20304915; http://dx.doi.org/10.1074/jbc.C110.113464
13. Deleault NR, Piro JR, Walsh DJ, Wang F, Ma J, Geoghegan JC, Supattapone S. Isolation of phospha-tidylethanolamine as a solitary cofactor for prion formation in the absence of nucleic acids. Proc Natl Acad Sci USA 2012; 109:8546-51; PMID:22586108; http://dx.doi.org/10.1073/pnas.1204498109
14. Deleault NR, Walsh DJ, Piro JR, Wang F, Wang X, Ma J, Rees JR, Supattapone S. Cofactor molecules maintain infectious conformation and restrict strain properties in purified prions. Proc Natl Acad Sci USA 2012; 109:E1938-46; PMID:22711839; http://dx.doi.org/10.1073/pnas.1206999109
15. Deleault NR, Harris BT, Rees JR, Supattapone S. Formation of native prions from minimal components in vitro. Proc Natl Acad Sci USA 2007; 104:9741-6; PMID:17535913; http://dx.doi.org/10.1073/pnas.0702662104
16. Geoghegan JC, Miller MB, Kwak AH, Harris BT, Supattapone S. Trans-dominant inhibition of prion propagation in vitro is not mediated by an accessory cofactor. PLoS Pathog 2009; 5:e1000535; PMID:19649330; http://dx.doi.org/10.1371/jour-nal.ppat.1000535
17. Gonzalez-Montalban N, Makarava N, Ostapchenko VG, Savtchenk R, Alexeeva I, Rohwer RG, Baskakov I V. Highly efficient protein misfolding cyclic amplification. PLoS Pathog 2011; 7:e1001277; PMID:21347353; http://dx.doi.org/10.1371/journal.ppat.1001277
18. Imamura M, Kato N, Yoshioka M, Okada H, Iwamaru Y, Shimizu Y, Mohri S, Yokoyama T, Murayama Y. Glycosylphosphatidylinositol anchor-dependent stimulation pathway required for generation of baculovirus-derived recombinant scrapie prion protein. J Virol 2011; 85:2582-8; PMID:21228241; http://dx.doi.org/10.1128/JVI.02098-10
19. Barria MA, Mukherjee A, Gonzalez-Romero D, Morales R, Soto C. De novo generation of infectious prions in vitro produces a new disease phenotype. PLoS Pathog 2009; 5:e1000421; PMID:19436715; http://dx.doi.org/10.1371/journal.ppat.1000421
20. Polymenidou M, Moos R, Scott M, Sigurdson C, Shi YZ, Yajima B, Hafner-Bratkovic I, Jerala R, Hornemann S, Wuthrich K, et al. The POM monoclonals: a comprehensive set of antibodies to non-overlapping prion protein epitopes. PLoS One 2008; 3:e3872; PMID:19060956; http://dx.doi.org/10.1371/journal.pone.0003872
21. Baral PK, Wieland B, Swayampakula M, Polymenidou M, Rahman MH, Kav NN, Aguzzi A, James MN. Structural studies on the folded domain of the human prion protein bound to the Fab fragment of the antibody POM1. Acta Crystallogr D Biol Crystallogr 2012; 68:1501-12; PMID:23090399; http://dx.doi.org/10.1107/S0907444912037328
22. Féraudet C, Morel N, Simon S, Volland H, Frobert Y, Créminon C, Vilette D, Lehmann S, Grassi J. Screening of 145 anti-PrP monoclonal antibodies for their capacity to inhibit PrPSc replication in infected cells. J Biol Chem 2005; 280:11247-58; PMID:15618225; http://dx.doi.org/10.1074/jbc.M407006200
23. Ma J. The role of cofactors in prion propagation and infectivity. PLoS Pathog 2012; 8:e1002589; PMID:22511864; http://dx.doi.org/10.1371/journal.ppat.1002589
24. Wang F, Ma J. Role of lipid in forming an infectious prion? Acta Biochim Biophys Sin (Shanghai) 2013; 45:485-93; PMID:23583976; http://dx.doi.org/10.1093/abbs/gmt038
25. Wang F, Yang F, Hu Y, Wang X, Wang X, Jin C, Ma J. Lipid interaction converts prion protein to a PrPSc-like proteinase K-resistant conformation under physiological conditions. Biochemistry 2007; 46:7045-53; PMID:17503780; http://dx.doi.org/10.1021/bi700299h
26. Wang F, Yin S, Wang X, Zha L, Sy MS, Ma J. Role of the highly conserved middle region of prion protein (PrP) in PrP-lipid interaction. Biochemistry 2010; 49:8169-76; PMID:20718504; http://dx.doi.org/10.1021/bi101146v
27. Kazlauskaite J, Pinheiro TJ. Aggregation and fibril-lization of prions in lipid membranes. Biochem Soc Symp 2005; 211-22; PMID:15649144
28. Kazlauskaite J, Sanghera N, Sylvester I, Vénien-Bryan C, Pinheiro TJ. Structural changes of the prion protein in lipid membranes leading to aggregation and fibrillization. Biochemistry 2003; 42:3295-304; PMID:12641461; http://dx.doi.org/10.1021/bi026872q
29. Morillas M, Swietnicki W, Gambetti P, Surewicz WK. Membrane environment alters the conformational structure of the recombinant human prion protein. J Biol Chem 1999; 274:36859-65; PMID:10601237; http://dx.doi.org/10.1074/jbc.274.52.36859
30. Adler V, Zeiler B, Kryukov V, Kascsak R, Rubenstein R, Grossman A. Small, highly structured RNAs participate in the conversion of human recom-binant PrP(Sen) to PrP(Res) in vitro. J Mol Biol 2003; 332: 47-57; PMID:12946346; http://dx.doi.org/10.1016/S0022-2836(03)00919-7
31. Gomes MP, Millen TA, Ferreira PS, e Silva NL, Vieira TC, Almeida MS, Silva JL, Cordeiro Y. Prion protein complexed to N2a cellular RNAs through its N-terminal domain forms aggregates and is toxic to murine neuroblastoma cells. J Biol Chem 2008; 283:19616-25; PMID:18456654; http://dx.doi.org/10.1074/jbc.M802102200
32. Li J, Browning S, Mahal SP, Oelschlegel AM, Weissmann C. Darwinian evolution of prions in cell culture. Science 2010; 327:869-72; PMID:20044542; http://dx.doi.org/10.1126/science.1183218
33. Timmes AG, Moore RA, Fischer ER, Priola SA. Recombinant prion protein refolded with lipid and RNA has the biochemical hallmarks of a prion but lacks in vivo infectivity. PLoS One 2013; 8:e71081; http://dx.doi.org/10.1371/journal.pone.0071081; PMID:23936256
34. Collinge J, Clarke AR. A general model of prion strains and their pathogenicity. Science 2007; 318:930-6; PMID:17991853; http://dx.doi.org/10.1126/science.1138718
35. Schulz-Schaeffer WJ, Tschöke S, Kranefuss N, Dröse W, Hause-Reitner D, Giese A, Groschup MH, Kretzschmar HA. The paraffin-embedded tissue blot detects PrP(Sc) early in the incubation time in prion diseases. Am J Pathol 2000; 156:51-6; PMID:10623653; http://dx.doi.org/10.1016/S0002-9440(10)64705-0
36. Wang X, Bowers SL, Wang F, Pu XA, Nelson RJ, Ma J. Cytoplasmic prion protein induces forebrain neu-rotoxicity. Biochim Biophys Acta 2009; 1792:555-63; PMID:19281844; http://dx.doi.org/10.1016/j.bbadis.2009.02.014
37. Wang F, Wang X, Ma J. Conversion of bacteri-ally expressed recombinant prion protein. Methods 2011; 53:208-13; PMID:21176786; http://dx.doi.org/10.1016/j.ymeth.2010.12.013